topical organogel with nitroglycerin

DRUG2 trials

Sponsors

MediQuest Therapeutics

Conditions

Raynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune DiseaseRaynaud's Disease

Phase 2

Lab Study of MQX-503 in Treatment of Raynaud's

CompletedNCT00253331

MediQuest TherapeuticsRaynaud Disease, Raynaud Disease Secondary to Scleroderma, Raynaud Secondary to Other Autoimmune Disease

Start: 2004-11-30End: 2005-09-30Target: 36Updated: 2007-05-30

Phase 3

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

CompletedNCT00266669

MediQuest TherapeuticsRaynaud's Disease

Start: 2005-12-31End: 2006-05-31Target: 200Updated: 2007-08-08